Author

Anne M. Robinson 1

1 Abbvie Inc, North Chicago, United States

BURDEN OF DISEASE IN PAEDIATRIC PATIENTS WITH MODERATE VERSUS SEVERE CROHN’S DISEASE IN THE IMAGINE 1 TRIAL

Frank Ruemmele, Jeffrey S Hyams, Joel Rosh, Marla C. Dubinsky, James Markowitz, Anne Griffiths, Dan Turner, Samantha Eichner, Andreas Lazar, Anne M. Robinson, Bidan Huang, Roopal B Thakkar

CLINICAL BENEFIT OF ADALIMUMAB DOSE ADJUSTMENT FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE IN EXTEND

Jean-Frederic Colombel, Paul Rutgeerts, William Sandborn, Douglas C. Wolf, Walter Reinisch, Gert Van Assche, Samantha Eichner, Joel Petersson, Anne M. Robinson, Roopal B Thakkar

High versus standard adalimumab induction dosing regimens in patients with moderately to severely active ulcerative colitis: results from the SERENE-UC induction study

Julian Panés, Jean-Frederic Colombel, Geert R. D'Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin-Biroulet, Edward Loftus, Jr, Silvio Danese, Edouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Jessica Lefebvre, Thao Doan, Nisha V. Kwatra, Nael M. Mostafa, Wangang Xie, Bidan Huang, Joel Petersson;;

LONG-TERM SAFETY OF ADALIMUMAB IN CLINICAL TRIALS IN ADULT PATIENTS WITH CROHN’S DISEASE OR ULCERATIVE COLITIS

Jean-Frederic Colombel, Remo Panaccione, Subrata Ghosh, William Sandborn, Paul Rutgeerts, Stephen B Hanauer, Walter Reinisch, Laurent Peyrin-Biroulet, Anne M. Robinson, Winnie Lau, Bidan Huang, Brandee L Pappalardo, Holly A. read

SUPERIOR ENDOSCOPIC AND DEEP REMISSION OUTCOMES IN ADULTS WITH MODERATE TO SEVERE CROHN'S DISEASE MANAGED WITH TREAT TO TARGET APPROACH VERSUS CLINICAL SYMPTOMS: DATA FROM CALM

Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukas, Filip Baert, T. Vanásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hebuterne, Simon Travis, Silvio Danese, Walter Reinisch, William Sandborn, Paul Rutgeerts, Daniel W. Hommes, Stefan Schreiber, Ezequiel Neimark, Bidan Huang, Qian Z

EFFICACY AND SAFETY OF ADALIMUMAB IN CHINESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Baili CHEN, Xiang Gao, Jie Zhong, Jianlin Ren, Xuan Zhu, Zhanju Liu, Kaichun Wu, Jasmina Kalabic, Bidan Huang, Thao Doan, Anne M. Robinson, Minhu Chen

PREDICTORS OF HOSPITALIZATION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS FROM ULTRA 1 AND ULTRA 2

Brian G. Feagan, William Sandborn, Walter Reinisch, Subrata Ghosh, Anne M. Robinson, Andreas Lazar, Martha Skup, Roopal B Thakkar

EXPOSURE-EFFICACY RELATIONSHIP (ER) FOR ADALIMUMAB DURING INDUCTION PHASE OF TREATMENT OF ADULT PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS (UC)

Nael M. Mostafa, Doerthe Eckert, Rajendra S Pradhan, Sven Mensing, Anne M. Robinson, Stephen B Hanauer, Jean-Frederic Colombel, Roopal B Thakkar, Walid Awni, William Sandborn

PYRAMID REGISTRY: LONG-TERM SAFETY OF ADALIMUMAB BY AGE IN PATIENTS WITH CROHN’S DISEASE

Jean-Frederic Colombel, Geert R. D'Haens, Walter Reinisch, Edward V Loftus Jr, Remo Panaccione, Jack Satsangi, Gabriela Alperovich, Sofie Berg, Jasmina Kalabic, Mareike Bereswill, Joel Petersson, Anne M. Robinson

SUSTAINED RESOLUTION OF EXTRAINTESTINAL MANIFESTATIONS IN PATIENTS WITH CROHN?S DISEASE RECEIVING ADALIMUMAB

Edouard Louis, Robert Löfberg, Walter Reinisch, David A Schwartz, Jen-Fue Maa, Sofie Berg, Bidan Huang, Anthony W. Wang, Anne M. Robinson, Brandee L Pappalardo

Item 1 - 10 / 25
1
2 3